Countries covered: United States
The U.S. point-of-care (POC) diagnostic test market is expected to reach revenues over $900 million in 2008, at a compound annual growth rate of 8.8%, due to technological advancements in POC testing equipment and continued market demand.
This report offers you the essential information needed to remain competitive in this highly evolving market. This study is designed to present the most up-to-date projections and data within the complex world of POC diagnostics. A thorough description of emerging products and conditions addressed as well as advancements in the U.S. market, Theta’s report will aid your organization by providing valuable market information.
This market research study analyses the POC market composition and dynamics, market size and participants, demographics, economic issues and regulatory issues are discussed. Historical market data are provided for each of the years 1998 through 2002, and forecast data are provided for each year 2003 through 2008.
Areas of POC testing covered in this report include:
- Infectious diseases
- Cardiac markers
- Coagulation
- Osteoporosis
- Drugs of abuse
- Miscellaneous rapid tests
An essential strategic resource, Theta’s Point-of-Care Testing: U.S. Markets and Progress provides the answers to the following questions:
- What new products are emerging in the POC test kit market?
- What effect are POC test kits having on the healthcare market in general, on physicians, on laboratories, etc.?
- How do end-users view the new test kits that are coming on the market?
- Who are the leading participants in the market?
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports: Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Preventive Healthcare Technologies, Products and Markets
2009 Worldwide Diagnostics Market Research Bundle
Monitoring Health Through Novel Technologies: Where Are We with Point-of-Care Diagnostics?
Emerging Markets for Microfluidic Applications
Glucose Monitoring Clinical Trial Analysis
Minimally Invasive Blood Glucose Monitoring device Clinical Trial Analysis
Non-Invasive Blood Glucose Monitoring device Clinical Trial Analysis
Medical Biosensors Market 2008-2012
|